Clinical Trial Update: Dose-Escalation Study of Carboplatin Administration Into the Brain for Glioblastoma Multiforme [Phase 1]

View source ↗

Summary

A phase 1 dose-escalation trial evaluating carboplatin delivered into the brain for glioblastoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: North Bristol NHS Trust | Conditions: Glioblastoma Multiforme | Phase 1 | Status: WITHDRAWN